About Unlearn
Unlearn is a healthcare AI company that aims to revolutionize clinical development by integrating AI and digital twins of patients. The company’s core mission is to make clinical trials smarter, faster, and more robust, ultimately accelerating the delivery of life-saving treatments to patients. Unlearn’s approach leverages data, AI, and digital twins to enhance decision-making throughout the entire clinical trial lifecycle, from initial design to post-readout analysis.
For physicians involved in clinical research, Unlearn offers tools to strengthen various stages of a study. This includes optimizing study design by pressure-testing eligibility criteria, endpoints, and sample sizes with simulated digital twins before protocol finalization. During the trial, digital twins can sharpen interim analyses and allow for re-running design scenarios as new evidence emerges. After readout, Unlearn’s technology can unlock more information from collected data, providing a clearer signal of efficacy in both randomized and single-arm studies by using digital twins as comparators. This can lead to smaller study designs, reduced control arm sizes, and faster enrollment times.
Focus Areas
Business Intelligence
| Technology | AI-powered digital twin technology, generative machine learning models, proprietary DiGenesis™ process, PROCOVA™ (Prognostic Covariate Adjustment) statistical approach, TrialPioneer (unified workspace for trial planning) |
What Physicians Need to Know
For physicians, Unlearn's technology offers the potential for more efficient and robust clinical trials. This can translate to faster development of new treatments, especially in areas like neurodegenerative diseases and oncology, by optimizing trial design, reducing patient burden in control arms, and providing clearer insights from study data. The use of digital twins can help in making more confident decisions throughout a study, potentially accelerating the availability of life-saving therapies.
Videos
News, demos, and interviews about Unlearn.
Videos load interactively. If none appear, search YouTube for Unlearn →
Frequently Asked Questions
Investors
Who's funded Unlearn.
Related Companies
ClinicalTrials.gov is a publicly accessible website and online database of clinical research studies, managed by the National Library of Medicine (NLM) at the National Institutes of Health (NIH). It serves as a central resource for patients, their families, healthcare professionals, and researchers to access comprehensive information on publicly and privately supported clinical studies across a […]
InsightRX provides AI-powered precision medicine software designed to optimize drug therapy from clinical development to the point of care. For physicians and clinical teams, InsightRX offers solutions like InsightRX Nova for Bayesian model-informed dosing, which individualizes drug regimens using validated pharmacokinetic models and real-time patient data. This helps clinicians achieve therapeutic targets more rapidly and […]
Indica Labs is a global leader in AI-powered digital pathology software and services, providing comprehensive solutions for quantitative evaluation and management of whole slide images. Their flagship platforms, HALO® and HALO AI, leverage artificial intelligence and computer vision algorithms to enable fast and precise analysis of tissue samples, which is critical for advancing research and […]
Triomics is an oncology AI company dedicated to transforming how cancer centers manage complex clinical information. The company’s platform utilizes AI agents to meticulously read and interpret comprehensive longitudinal patient records, converting unstructured clinical data—such as notes, pathology reports, imaging results, and genomic panels—into structured, verifiable outputs. This process significantly reduces the manual burden on […]
ClinTrialMatch is an AI-powered digital health platform designed to optimize patient recruitment, enrollment, and retention in clinical trials. The platform aims to bridge the gap between patients seeking treatment options and clinical trials needing participants by leveraging AI-driven insights. It is currently an early-stage platform undergoing development and pilot collaboration. For physicians, ClinTrialMatch offers a […]
Evaxion Biotech is a pioneering clinical-stage TechBio company that leverages its proprietary, clinically validated, and scalable AI platform, AI-Immunology™, to decode the human immune system. This platform is used to discover and develop novel immunotherapies for cancer, infectious diseases, and increasingly, autoimmune diseases. The company’s mission is to transform patients’ lives by providing inventive and […]


